Detalhe da pesquisa
1.
Contribution of chemotherapy to improved prognosis in stage 4 gastric cancer: trend analysis of a regional population-based cancer registry in Japan.
Int J Clin Oncol
; 26(2): 378-386, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33151441
2.
Three cases of histologically proven hepatic epithelioid hemangioendothelioma evaluated using a second-generation microbubble contrast medium in ultrasonography: case reports.
BMC Gastroenterol
; 19(1): 187, 2019 Nov 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31727083
3.
Immune response of cytotoxic T lymphocytes and possibility of vaccine development for hepatitis C virus infection.
J Biomed Biotechnol
; 2010: 263810, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20508848
4.
Increased expression of immuno-inhibitory molecules on peripheral blood lymphocytes may suppress disease progression in autoimmune hepatitis.
Hepatol Res
; 45(11): 1152-4, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25581267
5.
Efficacy of direct-acting antiviral treatment for chronic hepatitis C: A single hospital experience.
World J Hepatol
; 10(1): 88-94, 2018 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-29399282
6.
The Effect of New Therapeutic and Diagnostic Agents on the Prognosis of Hepatocellular Carcinoma in Japan An Analysis of Data from the Kanagawa Cancer Registry
Asian Pac J Cancer Prev
; 18(9): 2471-2476, 2017 09 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28952279
7.
Interleukin-4 and CpG oligonucleotide therapy suppresses the outgrowth of tumors by activating tumor-specific Th1-type immune responses.
Oncol Rep
; 27(6): 1765-71, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22426807
8.
Primary micropapillary carcinoma of the colon: a case report and literature review.
Clin J Gastroenterol
; 4(2): 99-103, 2011 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26190714
9.
Cyclooxygenase-2 gene promoter polymorphisms affect susceptibility to hepatitis C virus infection and disease progression.
Hepatol Res
; 40(12): 1219-26, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20880066
10.
Strong CD8(+) T-cell responses against tumor-associated antigens prolong the recurrence-free interval after tumor treatment in patients with hepatocellular carcinoma.
J Gastroenterol
; 45(4): 451-8, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19936602